STOCK TITAN

Ultralife (ULBI) Stock News

ULBI Nasdaq

Welcome to our dedicated page for Ultralife news (Ticker: ULBI), a resource for investors and traders seeking the latest updates and insights on Ultralife stock.

Ultralife Corporation reports developments in power solutions, battery products, and communications systems for government/defense and commercial customers. The company operates through Battery & Energy Products and Communications Systems, with updates often covering rechargeable and non-rechargeable batteries, charging systems, communications and electronics accessories, custom-engineered systems, and demand from medical, industrial, oil and gas, safety, security, and energy markets.

Recurring news for ULBI includes quarterly operating results, segment sales and margins, backlog, order timing, new product programs, acquisition integration following Electrochem Solutions, and operational actions affecting manufacturing capacity and efficiency.

Rhea-AI Summary

Ultralife (NASDAQ: ULBI) reported Q1 2026 results: revenue $47.4M (down 6.5% YoY), gross profit $10.1M (21.3% margin), operating loss of $0.2M including $1.7M one-time costs, and GAAP EPS ($0.03). Adjusted EBITDA was $3.2M; backlog reached a record $115.1M. The company cited lost production days, higher utility costs, weaker Communications Systems orders, and continued investment in new product development as drivers of results.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.32%
Tags
-
Rhea-AI Summary

Ultralife (NASDAQ: ULBI) will report first quarter results for the period ended March 31, 2026 before markets open on May 8, 2026. Management will host an investor conference call and simultaneous webcast at 8:30 AM ET on May 8, 2026 with replay available on the investor website.

Phone participants must pre-register to receive dial-in details and a personal identification number.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.5%
Tags
earnings date
-
Rhea-AI Summary

Ultralife (NASDAQ:ULBI) reported Q4 2025 revenue of $48.5M, up 10.6% year-over-year, with gross profit of $12.1M (24.9% margin). The company recorded a $12.2M intangible-asset impairment, producing a GAAP loss of $7.4M (EPS -$0.45).

Adjusted EBITDA was $5.7M (11.7% of sales) and backlog rose to $110.2M, a 22% increase versus Q3 2025. Battery & Energy Products sales grew 15.1% to $45.9M; Communications Systems sales fell 35.2% to $2.6M.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.61%
Tags
Rhea-AI Summary

Ultralife (NASDAQ: ULBI) will report fourth-quarter results for the period ended Dec 31, 2025 before market open on Mar 10, 2026. Management will host an investor conference call and simultaneous webcast at 8:30 AM ET that day.

Participants dialing by phone must pre-register using the company link to receive dial-in details and a personal identification number. A live webcast and a replay will be available in the Events & Presentations section of the company website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags
earnings date
-
Rhea-AI Summary

Ultralife (NASDAQ: ULBI) reported Q3 2025 results: revenue $43.4M (+21.5% YoY; $36.6M ex-Electrochem, +2.5%), gross profit $9.6M (22.2% margin vs 24.3% a year ago), and GAAP EPS ($0.07) vs $0.02 prior year. The company recorded a $1.1M one-time charge (including $0.5M to close Calgary) leading to an operating loss of $1.0M; adjusted EBITDA $2.0M. Backlog exited Q3 at $90.1M vs $84.5M in Q2. Management expects Calgary closure complete in Q1 2026 with ~$0.8M estimated annual savings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.84%
Tags
-
Rhea-AI Summary

Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2025 before the market opens on Tuesday, November 18, 2025. Management will host an investor conference call and simultaneous webcast at 8:30 AM ET on November 18, 2025.

Phone participants are required to pre-register at the provided registration link to receive dial-in details and a personal identification number. A live webcast will be available in the Events & Presentations section of the company website, and a replay will be posted shortly after the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.14%
Tags
earnings date
Rhea-AI Summary

Ultralife (NASDAQ: ULBI) filed a Form 12b-25 on Nov 7, 2025, notifying the SEC of a late Form 10-Q for the quarter ended Sept 30, 2025. The company said the late filing follows the conclusion of a transition services agreement with Integer after Ultralife completed its acquisition of Electrochem on Oct 31, 2024, and that Electrochem has moved from Integer's systems to Ultralife systems.

Ultralife stated it needs extra time for finalizing third-quarter results and completing the independent accountant review without unreasonable effort or expense, and it expects to file the Form 10-Q by Nov 17, 2025 in accordance with Rule 12b-25.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.56%
Tags
none
-
Rhea-AI Summary

Ultralife Corporation (NASDAQ: ULBI) has secured a $5.2 million award from the U.S. Defense Logistics Agency (DLA) for its BA-5390 military batteries. The contract involves supplying lithium manganese dioxide, non-rechargeable batteries, with deliveries scheduled throughout 2026 and completion in early 2027.

This follows their previous significant BA-5390 award in 2021, which was a multi-year contract valued at up to $9.9 million. The company's BA-5390 batteries are known for their long life, safety record, and reliability in challenging conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.52%
Tags
none
-
Rhea-AI Summary

Ultralife Corporation (NASDAQ: ULBI) reported mixed Q2 2025 results with revenue increasing 13.0% to $48.6 million, primarily driven by the Electrochem acquisition. However, organic performance showed challenges with Communications Systems sales declining 57.2%. The company reported operating income of $2.3 million and GAAP EPS of $0.05, down from $0.18 in Q2 2024.

Key metrics include gross profit of $11.6 million (23.9% margin), Adjusted EBITDA of $4.1 million (8.5% of sales), and a backlog of $89 million. The company faced headwinds from tariffs and unfavorable product mix but managed to prepay $2.7 million in acquisition debt. Management expects improved performance in H2 2025 and 2026, driven by Communications Systems rebound and new product initiatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.03%
Tags
Rhea-AI Summary

Ultralife Corporation (NASDAQ: ULBI) has scheduled its second quarter 2025 financial results announcement for August 7, 2025, before market opening. The company will host an investor conference call and webcast at 12:00 PM ET on the same day.

Participants joining by phone must pre-register through a provided link to ensure smooth connection. A live webcast will be accessible through the Events & Presentations section of Ultralife's investor website, with a replay available shortly after the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.92%
Tags
conferences earnings

FAQ

What is the current stock price of Ultralife (ULBI)?

The current stock price of Ultralife (ULBI) is $6.07 as of May 15, 2026.

What is the market cap of Ultralife (ULBI)?

The market cap of Ultralife (ULBI) is approximately 101.6M.